Suppression of NF-κβ signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 2, 2009, Pages 251-259

  Kuhad, Anurag ^a   Bishnoi, Mahendra ^a   Tiwari, Vinod ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Acetylcholinesterase; Apoptosis; Caspase 3; Diabetic encephalopathy; IL 1 ; NF ; Oxidative nitrosative stress; TNF ; Tocotrienol

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA TOCOTRIENOL; CASPASE 3; GLUCOSE; GLUTAMATE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 1BETA; STREPTOZOCIN; SYNAPTOTAGMIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; HIPPOCAMPUS; LATENT PERIOD; MALE; MAZE TEST; NERVE CELL NECROSIS; NEUROTRANSMISSION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RECEPTOR DOWN REGULATION; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; ANIMAL; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; METABOLISM; SIGNAL TRANSDUCTION;

RATTUS;

ANIMALS; BLOOD GLUCOSE; COGNITION DISORDERS; DIABETES MELLITUS, EXPERIMENTAL; INSULIN; LIPID PEROXIDATION; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; STREPTOZOCIN; TOCOTRIENOLS;

EID: 59649122815     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.12.012     Document Type: Article

References (55)

1. Ahn K.S., Sethi G., Krishnan K., and Aggarwal B.B. Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J Biol Chem 282 (2007) 809-820
2. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., and Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61 (2004) 661-666
3. Bajt M.L., Ho Y.S., Vonderfecht S.L., and Jaeschke H. Reactive oxygen as modulator of TNF and fas receptor-mediated apoptosis in vivo: studies with glutathione peroxidase-deficient mice. Antioxid Redox Signal 4 (2002) 733-740
4. Barrett G.L. The p75 neurotrophin receptor and neuronal apoptosis. Prog Neurobiol 61 (2000) 205-229
5. Begum A.N., and Terao J. Protective effect of alpha-tocotrienol against free radical-induced impairment of erythrocyte deformability. Biosci Biotechnol Biochem 66 (2002) 398-403
6. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5 (2002) 561-568
7. Brands A.M., Kessels R.P., de Haan E.H., Kappelle L.J., and Biessels G.J. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur J Pharmacol 490 (2004) 159-168
8. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
9. Cande C., Vahsen N., Garrido C., and Kroemer G. Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death Differ 11 (2004) 591-595
10. Claiborne A. Catalase activity. In: Greenwald R.A. (Ed). Handbook of methods for oxygen radical research (1985), CRC Press, Boca Raton 283-284
11. Cumiskey D., Butler M.P., Moynagh P.N., and O'connor J.J. Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation. Brain Res 1136 (2007) 13-19
12. Ellman G.L., Courtney D.K., Andres V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7 (1961) 88-95
13. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Rev 23 (2002) 599-622
14. Fukuhara M., Matsumura K., Wakisaka M., Takata Y., Sonoki K., Fujisawa K., et al. Hyperglycemia promotes microinflammation as evaluated by C-reactive protein in the very elderly. Intern Med 46 (2007) 207-212
15. Gispen W.H., and Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23 (2000) 542-549
16. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev 18 (2004) 2195-2224
17. Hirata H., Hibasami H., Yoshida T., Ogawa M., Matsumoto M., Morita A., et al. Nerve growth factor signaling of p75 induces differentiation and ceramide-mediated apoptosis in Schwann cells cultured from degenerating nerves. Glia 36 (2001) 245-258
18. Hughes G., Murphy M.P., and Ledgerwood E.C. Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants. Biochem J 389 (2005) 83-89
19. Jacobson A.M., and Weinger K. Treating depression in diabetic patients: is there an alternative to medications?. Ann Intern Med 129 (1998) 656-657
20. Janssen-Heininger Y.M., Macara I., and Mossman B.T. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am J Respir Cell Mol Biol 20 (1999) 942-952
21. Jollow D.J., Mitchell J.R., Zampaglione N., and Gillette J.R. Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzenoxide as the hepatotoxic intermediate. Pharmacology 11 (1974) 151-169
22. Kamat J.P., and Devasagayam T.P. Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci Lett 195 (1995) 1790 182
23. Kanaya Y., Doi T., Sasaki H., Fujita A., Matsuno S., Okamoto K., et al. Rice bran extract prevents the elevation of plasma peroxylipid in KKAy diabetic mice. Diabetes Res Clin Pract 66 (2004) S157-S160
24. Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 274 (1999) 27339-27342
25. Kim E.K., Kwon K.B., Han M.J., Song M.Y., Lee J.H., Lv N., et al. Coptidis rhizoma extract protects against cytokine-induced death of pancreatic beta-cells through suppression of NF-kappaB activation. Exp Mol Med 39 (2007) 149-159
26. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186 (1978) 189-195
27. Konrad R.J., Mikolaenko I., Tolar J.F., Liu K., and Kudlow J.E. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic β-cell O-GlcNAc-selective-N-acetyl-β-d-glucosaminidase. Biochem J 356 (2001) 31-41
28. Kowluru R.A., and Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond) 16 (2007) 4-8
29. Kuhad A., and Chopra K. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur J Pharmacol 576 (2007) 34-42
30. Kuhad A., and Chopra K. Effect of sesamol on diabetes-associated cognitive decline in rats. Exp Brain Res 185 (2008) 411-420
31. Lee M.W., Park S.C., Kim J.H., Kim I.K., Han K.S., Kim K.Y., et al. The involvement of oxidative stress in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in HeLa cells. Cancer Lett 182 (2002) 75-82
32. Li Z.G., Zhang W., and Sima A.A. The role of impaired insulin/IGF action in primary diabetic encephalopathy. Brain Res 1037 (2005) 12-24
33. Lobnig B.M., Kromeke O., Optenhostert-Porst C., and Wolf O.T. Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications. Diabetic Med 23 (2005) 32-39
34. Maiese K., Chong Z.Z., and Shang Y.C. Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem 14 (2007) 1729-1738
35. Mastrocola R., Restivo F., Vercellinatto I., Danni O., Brignardello E., Aragno M., et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol 187 (2005) 37-44
36. Mijnhout G.S., Scheltens P., Diamant M., Biessels G.J., Wessels A.M., Simsek S., et al. Diabetic encephalopathy: a concept in need of a definition. Diabetologia 49 (2006) 1447-1448
37. Morris R.G., Garrud P., Rawlins J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982) 681-683
38. Murray J., Taylor S.W., Zhang B., and Ghosh S. Oxidative damage to mitochondrial complex I due to peroxynitrite. J Biol Chem 278 (2003) 37223-37230
39. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
40. Northam E.A., Rankins D., and Cameron F.J. Therapy insight: the impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol 2 (2006) 78-86
41. Osakada F., Hashino A., Kume T., Katsuki H., Kaneko S., and Akaike A. Alpha-tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons. Neuropharmacology 47 (2004) 904-915
42. Piette J., Piret B., Bonizzi G., Schoonbroodt S., Merville M.P., Legrand-Poels S., et al. Multiple redox regulation in NF-kappaB transcription factor activation. Biol Chem 378 (1997) 1237-1245
43. Reske-Nielsen E., Svendsen K., and Sogaard H. Cerebral emboli as a result of "mute" juvenile endocarditis. Acta Pathol Microbiol Scand 63 (1965) 321-332
44. Ryan C.M., Geckle M.O., and Orchard T.J. Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46 (2003) 940-948
45. Sanchez-Chavez G., and Salceda R. Effect of streptozotocin-induced diabetes on activities of cholinesterases in the rat retina. IUBMB Life 49 (2000) 283-287
46. Satoh J., Yagihashi S., and Toyota T. The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Exp Diabesity Res 4 (2003) 65-71
47. Schmidt A.M., Yan S.D., Wautier J.L., and Stern D. Activation of receptor for advanced glycation endproducts: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84 (1999) 489-497
48. Sen C.K., Khanna S., and Roy S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med 28 (2007) 692-728
49. Serbinova E.A., and Packer L. Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Methods Enzymol 234 (1994) 354-366
50. Serbinova E., Kagan V., Han D., and Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med 10 (1991) 263-275
51. Somfai G.M., Knippel B., Ruzicska E., Stadler K., Toth M., Salacz G., et al. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats. Neurochem Int 48 (2006) 746-752
52. Suzuki Y.J., Tsuchiya M., Wassall S.R., Choo Y.M., Govil G., Kagan V.E., et al. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry (1993) 10692-10699
53. Tuzcu M., and Baydas G. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur J Pharmacol 537 (2006) 106-110
54. Weber S.U., Thiele J.J., Han N., Luu C., Valacchi G., Weber S., and Packer L. Topical alpha-tocotrienol supplementation inhibits lipid peroxidation but fails to mitigate increased transepidermal water loss after benzoyl peroxide treatment of human skin. Free Radic Biol Med. 34 2 (2003) 170-176
55. Wills E.D. Mechanism of lipid peroxide formation in animals. Biochem J 99 (1965) 667-676